Topical Sirolimus 0.2% Gel for the Management of Tuberous Sclerosis Complex-Related Cutaneous Manifestations: An Interim Analysis of Postmarketing Surveillance in Japan

INTRODUCTION: Tuberous sclerosis complex (TSC) is a rare autosomal dominant genetic disorder affecting several organs, including skin. We sought to assess the real-world effectiveness and safety of a topical sirolimus 0.2% gel treatment for TSC-related cutaneous manifestations. METHODS: We conducted...

Descripción completa

Detalles Bibliográficos
Autores principales: Egami, Akemi, Takahashi, Shinji, Kokubo, Takeshi, Boggarapu, Sreedevi, Beresford, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149422/
https://www.ncbi.nlm.nih.gov/pubmed/36905480
http://dx.doi.org/10.1007/s13555-023-00914-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149422/
https://www.ncbi.nlm.nih.gov/pubmed/36905480
http://dx.doi.org/10.1007/s13555-023-00914-2

Ejemplares similares